Since the treatment of N-MVECs with hmel-1–CM stimulated neoangiogenesis and protected endothelial cells from tomatine inhibitory effects, we evaluated the release of VEGF by tumor cells before and after tomatine treatment. The gene discussed is VEGFA; the disease is neoplasm.